AAP IMPLANTATE (AAQ1.DE) Fundamental Analysis & Valuation

FRA:AAQ1 • DE000A3H2101

Current stock price

1.39 EUR
+0.03 (+2.21%)
Last:

This AAQ1.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. AAQ1.DE Profitability Analysis

1.1 Basic Checks

  • AAQ1 had negative earnings in the past year.
  • AAQ1 had a negative operating cash flow in the past year.
  • In the past 5 years AAQ1 always reported negative net income.
  • AAQ1 had a negative operating cash flow in each of the past 5 years.
AAQ1.DE Yearly Net Income VS EBIT VS OCF VS FCFAAQ1.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M

1.2 Ratios

  • AAQ1 has a Return On Assets of -25.96%. This is in the lower half of the industry: AAQ1 underperforms 77.05% of its industry peers.
  • AAQ1's Return On Equity of -38.70% is on the low side compared to the rest of the industry. AAQ1 is outperformed by 73.77% of its industry peers.
Industry RankSector Rank
ROA -25.96%
ROE -38.7%
ROIC N/A
ROA(3y)-27.22%
ROA(5y)-27.6%
ROE(3y)-50.99%
ROE(5y)-51.91%
ROIC(3y)N/A
ROIC(5y)N/A
AAQ1.DE Yearly ROA, ROE, ROICAAQ1.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60 -80 -100

1.3 Margins

  • With an excellent Gross Margin value of 87.45%, AAQ1 belongs to the best of the industry, outperforming 96.72% of the companies in the same industry.
  • In the last couple of years the Gross Margin of AAQ1 has remained more or less at the same level.
  • AAQ1 does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 87.45%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.81%
GM growth 5Y-0.65%
AAQ1.DE Yearly Profit, Operating, Gross MarginsAAQ1.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. AAQ1.DE Health Analysis

2.1 Basic Checks

  • AAQ1 does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for AAQ1 has been increased compared to 1 year ago.
  • The number of shares outstanding for AAQ1 has been increased compared to 5 years ago.
  • Compared to 1 year ago, AAQ1 has an improved debt to assets ratio.
AAQ1.DE Yearly Shares OutstandingAAQ1.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
AAQ1.DE Yearly Total Debt VS Total AssetsAAQ1.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • AAQ1 has an Altman-Z score of -0.04. This is a bad value and indicates that AAQ1 is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -0.04, AAQ1 is doing worse than 77.05% of the companies in the same industry.
  • AAQ1 has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
  • AAQ1's Debt to Equity ratio of 0.03 is amongst the best of the industry. AAQ1 outperforms 90.16% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z -0.04
ROIC/WACCN/A
WACC7.03%
AAQ1.DE Yearly LT Debt VS Equity VS FCFAAQ1.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

2.3 Liquidity

  • A Current Ratio of 2.40 indicates that AAQ1 has no problem at all paying its short term obligations.
  • AAQ1 has a Current ratio of 2.40. This is in the better half of the industry: AAQ1 outperforms 70.49% of its industry peers.
  • AAQ1 has a Quick Ratio of 1.24. This is a normal value and indicates that AAQ1 is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of AAQ1 (1.24) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.4
Quick Ratio 1.24
AAQ1.DE Yearly Current Assets VS Current LiabilitesAAQ1.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. AAQ1.DE Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 63.21% over the past year.
  • The Revenue has been growing slightly by 6.32% in the past year.
  • The Revenue has been growing slightly by 0.78% on average over the past years.
EPS 1Y (TTM)63.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%21.53%
Revenue 1Y (TTM)6.32%
Revenue growth 3Y0.1%
Revenue growth 5Y0.78%
Sales Q2Q%-3.32%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • The Revenue is expected to grow by 11.66% on average over the next years. This is quite good.
EPS Next Y65%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year15.38%
Revenue Next 2Y22.14%
Revenue Next 3Y12.95%
Revenue Next 5Y11.66%

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
AAQ1.DE Yearly Revenue VS EstimatesAAQ1.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 10M 20M 30M
AAQ1.DE Yearly EPS VS EstimatesAAQ1.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -0.5 -1 -1.5 -2 -2.5

More info and screens

Find the best growth stocksShow best growing peers

0

4. AAQ1.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • AAQ1 reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AAQ1. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AAQ1.DE Price Earnings VS Forward Price EarningsAAQ1.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AAQ1.DE Per share dataAAQ1.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 0.6 0.8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. AAQ1.DE Dividend Analysis

5.1 Amount

  • No dividends for AAQ1!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

AAQ1.DE Fundamentals: All Metrics, Ratios and Statistics

AAP IMPLANTATE

FRA:AAQ1 (4/1/2026, 7:00:00 PM)

1.39

+0.03 (+2.21%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A
Earnings (Next)04-30
Inst Owners22.38%
Inst Owner ChangeN/A
Ins Owners15.97%
Ins Owner ChangeN/A
Market Cap20.46M
Revenue(TTM)12.20M
Net Income(TTM)-3.63M
Analysts42.22
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.68
P/FCF N/A
P/OCF N/A
P/B 2.18
P/tB 2.72
EV/EBITDA N/A
EPS(TTM)-0.35
EYN/A
EPS(NY)-0.07
Fwd EYN/A
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0.83
BVpS0.64
TBVpS0.51
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -25.96%
ROE -38.7%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 87.45%
FCFM N/A
ROA(3y)-27.22%
ROA(5y)-27.6%
ROE(3y)-50.99%
ROE(5y)-51.91%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.81%
GM growth 5Y-0.65%
F-Score6
Asset Turnover0.87
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 32.08%
Cap/Sales 4.82%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.4
Quick Ratio 1.24
Altman-Z -0.04
F-Score6
WACC7.03%
ROIC/WACCN/A
Cap/Depr(3y)18.89%
Cap/Depr(5y)19.66%
Cap/Sales(3y)3.48%
Cap/Sales(5y)3.84%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)63.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%21.53%
EPS Next Y65%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)6.32%
Revenue growth 3Y0.1%
Revenue growth 5Y0.78%
Sales Q2Q%-3.32%
Revenue Next Year15.38%
Revenue Next 2Y22.14%
Revenue Next 3Y12.95%
Revenue Next 5Y11.66%
EBIT growth 1Y61.47%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year173.33%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y63.88%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y86.19%
OCF growth 3YN/A
OCF growth 5YN/A

AAP IMPLANTATE / AAQ1.DE Fundamental Analysis FAQ

What is the fundamental rating for AAQ1 stock?

ChartMill assigns a fundamental rating of 2 / 10 to AAQ1.DE.


What is the valuation status of AAP IMPLANTATE (AAQ1.DE) stock?

ChartMill assigns a valuation rating of 0 / 10 to AAP IMPLANTATE (AAQ1.DE). This can be considered as Overvalued.


How profitable is AAP IMPLANTATE (AAQ1.DE) stock?

AAP IMPLANTATE (AAQ1.DE) has a profitability rating of 1 / 10.